Filing Details

Accession Number:
0001181431-13-045290
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-16 16:29:07
Reporting Period:
2013-08-14
Filing Date:
2013-08-16
Accepted Time:
2013-08-16 16:29:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Pharmaceuticals Inc. PCRX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1545282 Taunia Markvicka C/O Pacira Pharmaceuticals, Inc.
5 Sylvan Way, Suite 100
Parsippany NJ 07054
Vice President, Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-14 14,700 $1.61 14,700 No 4 M Direct
Common Stock Disposition 2013-08-14 14,700 $37.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Disposition 2013-08-14 14,700 $0.00 14,700 $1.61
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,685 2020-09-01 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. The stock option vests as follows: 25% of the options vested on September 2, 2011; the remaining options vest in successive equal monthly installments over the subsequent 36 months.